PD-L1 expression in breast invasive ductal carcinoma with incomplete pathological response to neoadjuvant chemotherapy.
Ahmad AlhesaHeyam AwadSarah BloukhMahmoud Al-BalasMohammed El-SadoniDuaa QattanBilal AzabTareq SalehPublished in: International journal of immunopathology and pharmacology (2022)
Our findings indicate that PD-L1 protein expression in infiltrating immune cells was significantly reduced in breast tumors that developed incomplete PR following the exposure to NAC.